Nuria Roglans Ribas

Senior lecturer

ORCID: 0000-0002-5018-021X
Researcher ID: ABH-1242-2020
Knowledge area: Farmacologia

Teaching Innovation Groups: ORFILA: Grup d'Innovació Docent de Toxicologia

Contact Information
Department of Pharmacology, Toxicology and Medicinal Chemistry
Facultat Farmàcia. Diagonal 643
934024531
roglans(a)ub.edu

Academic training

Llicenciada en Farmàcia
Doctora en Farmàcia

Relevant publications

Baena, Miguel; Sanguesa, Gemma; Hutter, Natalia; Maria Beltran, Jose; Maria Sanchez, Rosa; Roglans, Nuria; Alegret, Marta; Carlos Laguna, Juan. Liquid fructose in Western-diet-fed mice impairs liver insulin signaling and causes cholesterol and triglyceride loading without changing calorie intake and body weight. In Journal of Nutritional Biochemistry. Volume 40. 2017 . Institutional Repository
Bentanachs, R.; Velázquez, A.M.; Sánchez, R.M.; Alegret, M.; Laguna, J.C.; Roglans, N. El ácido bempedoico como activador PPARalpha: nuevas perspectivas para el tratamiento de la esteatosis hepática en un modelo experimental de rata hembra. In Clínica e Investigación en Arteriosclerosis. 2021 . Institutional Repository
JC Laguna; N Roglans, R Bentanachs. Pemafibrato: ¿un fracaso PROMINENTe o una necesidad urgente de reposicionamiento terapéutico?. In Clínica e Investigación en Arteriosclerosis. Volume 35. 2023
Di Veroli B; Bentanachs R; Roglans N; Alegret M; Giona L; Profumo E; Berry A; Saso L; Laguna JC; Buttari B. Sex Differences Affect the NRF2 Signaling Pathway in the Early Phase of Liver Steatosis: A High-Fat-Diet-Fed Rat Model Supplemented with Liquid Fructose. In Cells. Volume 13. Number 15. 2024 . https://doi.org/10.3390/cells13151247
Bentanachs Roger; Miro Lluisa; Sanchez Rosa M.; Ramirez-Carrasco Patricia; Amat Concepcio; Alegret Marta; Perez Anna; Roglans Nuria; Laguna Juan C. Pemafibrate abrogates SLD in a rat experimental dietary model inducing a shift in fecal bile acids and microbiota composition. In Biomedicine & Pharmacotherapy. Volume 177. 2024 . Institutional Repository
Bentanachs, R.; Velazquez, A.; Roglans, N.; Alegret, M.; Laguna, JC. Increased DNL and PNPLA3 expression by liquid fructose are essential in the production of fatty liver and hypertriglyceridemia in non-obese HFD-fed rat model. In Atherosclerosis. Volume 355. 2022
Bentanachs, R.; Velázquez, A.; Roglans, N.; Laguna, JC.; Alegret, M. Ketohexokinase inhibition by bempedoic acid reduces fructose consumption in female rats fed a high-fat diet. In Atherosclerosis. Volume 355. 2022
Bentanachs Raset R.; Velazquez A. M.; Sala-Vila A.; Lazaro I.; Rodriguez-Morato J.; Sanchez R. M.; Alegret M.; Roglans N.; Laguna J. C. en Increased DNL and PNPLA3 expression by liquid fructose are essential in the production of fatty liver and hypertriglyceridemia in non-obese HFD-fed rat model. In Atherosclerosis. Volume 355. 2022
Puertas-Umbert, L.; Alonso, J.; Blanco-Casoliva, L.; Almendra-Pegueros, R.; Camacho, M.; Rodríguez-Sinovas, A.; Galán, M.; Roglans, N.; Laguna, JC.; Martínez-Gonzalez, J.; Rodríguez, C. Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice. In Biomedicine & Pharmacotherapy. Volume 184. Number 117876. 2025 . https://doi.org/10.1016/j.biopha.2025.117876